Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 5/20 | 0.49 |
| ▸ | CA2 | P00918 | 9/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | MME | P08473 | 3/20 | 0.45 |
| ▸ | GNPAT | O15228 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 2/20 | 0.44 |
| ▸ | CPA1 | P15085 | 2/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17903210 | 1.00 | ENPEP (0.49) | ENPEPCA2CA1MMEGNPAT | |
| SCHEMBL17903209 | 0.97 | CA2 (0.50) | ENPEPCA2CA1MMEACE | |
| SCHEMBL17903276 | 0.85 | CA2 (0.39) | ENPEPCA2CA1 | |
| SCHEMBL678158 | 0.83 | SLC7A5 (0.61) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL10789173 | 0.83 | SLC7A5 (0.61) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL9419220 | 0.83 | SLC7A5 (0.61) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL29657676 | 0.83 | SLC7A5 (0.61) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL678159 | 0.83 | SLC7A5 (0.61) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL30839475 | 0.83 | SLC7A5 (0.61) | ENPEPMMEACECPA1ACE2 | |
| SCHEMBL8082492 | 0.83 | MME (0.63) | MMEGNPATACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9486497-B2 | Treatment of immunocompromised conditions | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-11-08 | — | — | US | disclosed |